Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interferon beta-1b in hospitalized adults with COVID-19
IRCT20190804044429N1Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Mar 2020
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label trial of interferon beta-1b in coronavirus disease 2019 (COVID-19) and coronavirus pneumonia (2 arms), sponsored by Mazandaran University of Medical Sciences. Primary endpoints: Clinical efficacy, Laboratory response and 1 more. Started Mar 2020; status: completed.
02
Drugs
interferon beta-1b
03
Conditions
coronavirus disease 2019 (COVID-19)coronavirus pneumonia
Beyond the preview
Go deeper on IRCT20190804044429N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190804044429N1.